Found: 14
Select item for more details and to access through your institution.
Heterogeneity in the Identification of Potential Drug‐Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 706, doi. 10.1002/jcph.2020
- By:
- Publication type:
- Article
When Off‐Label Prescribing Becomes Politicized: Do No Harm.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 703, doi. 10.1002/jcph.2041
- By:
- Publication type:
- Article
Efficacy and Safety of Adjunctive Serotonin‐Dopamine Activity Modulators in Major Depression: A Meta‐Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 721, doi. 10.1002/jcph.2022
- By:
- Publication type:
- Article
A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 801, doi. 10.1002/jcph.2019
- By:
- Publication type:
- Article
Different Kinetics of Activated Clotting Time Among Uninterrupted Oral Anticoagulants During Catheter Ablation Procedure.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 792, doi. 10.1002/jcph.2018
- By:
- Publication type:
- Article
Clinical and Pharmacological Parameters Determine Relapse During Clopidogrel Treatment of Acute Coronary Syndrome.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 783, doi. 10.1002/jcph.2016
- By:
- Publication type:
- Article
Association Between Baseline Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Death Among Patients Tested for COVID‐19.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 777, doi. 10.1002/jcph.2015
- By:
- Publication type:
- Article
Periprocedural Myocardial Injury in High‐Risk Patients With NSTEMI Pretreated With Ticagrelor for Less or More Than 6 Hours Before PCI.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 770, doi. 10.1002/jcph.2014
- By:
- Publication type:
- Article
Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 812, doi. 10.1002/jcph.2013
- By:
- Publication type:
- Article
Infant Dextromethorphan and Dextrorphan Exposure via Breast Milk From Mothers Who Are CYP2D6 Extensive Metabolizers.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 747, doi. 10.1002/jcph.2012
- By:
- Publication type:
- Article
The Effects of Mannuronic Acid on IL‐1β, IL‐17A, STAT1, and STAT3 Gene Expressions and TLR2 and TLR4 Molecules in Multiple Sclerosis.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 762, doi. 10.1002/jcph.2008
- By:
- Publication type:
- Article
Risk of Pregabalin‐Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 756, doi. 10.1002/jcph.2009
- By:
- Publication type:
- Article
Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real‐World Data: A Pharmacokinetic–Pharmacodynamic Modeling Approach.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 733, doi. 10.1002/jcph.2007
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 6, p. 697, doi. 10.1002/jcph.1662
- Publication type:
- Article